SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Amgen reports XGEVA sales of $288 million in 3Q

Amgen reported worldwide XGEVA sales of $288 million in the third quarter.

AMGN

Related stories